Aims Whereas the effects of ageing on b-receptor mediated responses have been extensively studied in vitro and in vivo using the b-adrenoceptor agonist isoprenaline, little is known regarding ageing induced changes in responses to endogenous catecholamines. In the present study, we assessed age-related changes in cardiac responses to the endogenous b-adrenoceptor agonist adrenaline and the influence of age-related changes in arterial baroreflex function on these responses. Methods Adrenaline alone was infused in 14 young subjects, age 30±2 years (eight males, six females), and 18 older subjects (six males, 12 females), age 60±2 years, and together with ganglionic blockade (trimetaphan) in seven young and 11 older subjects. Adrenaline was infused at 3-4 incremental rates, each rate for 8 min. Cardiac function was assessed by echocardiography. Results Adrenaline alone, at infusion rates 20-160 ng kg −1 min −1 caused similar increases in heart rate in the two groups. In contrast, adrenaline caused larger increases in stroke volume, ejection fraction, cardiac index and systolic blood pressure and larger decreases in end-systolic wall stress and diastolic blood pressure in the young compared with older subjects. Older females exhibited the smallest increases in stroke volume index and ejection fraction. With concomitant ganglionic blockade, all above cardiovascular responses to adrenaline were similar in the young and older group. Plasma adrenaline increased similarly in the two groups.
Introduction of the major mechanisms for removal of the endogenous agonists out of the synaptic cleft. Decreased/absent uptake Both in animals and in humans ageing is associated with a decrease in b-adrenoceptor mediated responses of the will lead to higher effective concentrations in the synaptic cleft at similar rates of (endogenous) release or of exogenous cardiovascular system [1] . Nearly all studies on the interaction of ageing and b-adrenoceptor mediated responses have infusion for the endogenous agonists but will not affect the concentrations of isoprenaline. Cardiac transplant patients employed the synthetic agonist isoprenaline. Little is known regarding the effects of ageing on the cardiovascular responses have no cardiac neuronal uptake and this probably explains why, compared with control patients, they show increased to the endogenous neurotransmitters noradrenaline and adrenaline. In the intact organism, several differences cardiac responses to intravenous infusion of adrenaline but not of isoprenaline [5, 6] . Changes in cardiac neuronal between isoprenaline and the endogenous catecholamines preclude extrapolation of findings obtained with isoprenaline uptake occur with ageing although these changes have not yet been assessed in humans. The rat heart shows a to the endogenous agonists. In contrast to isoprenaline, both endogenous agonists have substantial a-receptor agonistic degeneration of sympathetic nerve terminals with ageing [7] , as well as decreased neuronal uptake of noradrenaline activity, both pre-and post-synaptically, which will influence the final haemodynamic responses. There are no consistent [3, 8] , although one study reported increased uptake [9] . In humans, only one study [10] has so far evaluated the reports on an age-related decrease in a-adrenoceptor mediated vasoconstrictor responses [2] , whereas presynaptic effects of ageing on cardiovascular responses to the endogenous catecholamine adrenaline. In this study responses of autoregulation of noradrenaline release via a 2 -adrenoceptors appears to decrease with age [2, 3] . Secondly, in contrast to blood pressure (BP), heart rate and leg vascular resistance to adrenaline at increasing infusion rates were evaluated in isoprenaline endogenous catecholamines are taken up by the young and older healthy normotensive subjects. Plasma adrenaline concentrations achieved in the two groups were and leg vascular resistance were also similar. Only systolic Experimental protocol BP showed a difference, i.e., an increase in the young, but not the older subjects, possibly indicating decreased inotropic Following a run-in study morning to acquaint the subjects with experimental procedures and personnel, on the first responses in the elderly. However, cardiac function was not evaluated, nor whether differences in arterial baroreflex study-morning adrenaline alone was administered and on the second study-morning adrenaline with concomitant activity masked differences in responsiveness to adrenaline. Ageing decreases the buffering capacity of the arterial trimetaphan. Study mornings were at least 4 days apart. On each study-morning, following a standardized liquid breakfast baroreflex [11, 12] , and this difference between young and older subjects clearly determines the extent of the responses the subjects remained supine until completion of the study. Two indwelling intravenous catheters were inserted, one in to a b-adrenoceptor agonist [e.g. 13] . In the present study, we therefore evaluated the effects of age on cardiac responses each forearm. A blood pressure cuff was applied to the arm that was not used for infusion and blood pressure was to adrenaline at increasing infusion rates without and with concomitant ganglionic blockade to eliminate differences in measured automatically with a Roche Arteriosonde (Roche Medical Electronics Inc., Cranbury, NJ). ECG electrodes arterial baroreflex activity.
were attached to measure heart rate by a Tektronic 414 monitor (Tektronic Inc. Beaverton, Oregon).
Methods
On the first study-morning, following a rest period of at least 60 min adrenaline was started at 20 ng kg
Subjects and increased to 40, 80, 120 or 160 ng kg −1 min −1 until the heart rate had increased by 20-25 beats min −1 or the Adrenaline without trimetaphan was administered to 14 young normotensive subjects (age 21-40 years, mean 30±2; diastolic blood pressure decreased by 15 mm Hg. Each dose was infused for 8 min. On the second study-morning, eight males and six females) and 18 older normotensive subjects (age 50-73 years, mean 60±2; six males and 12 subjects were first titrated with trimetaphan (Arfonad). The latter was started at 20 mg kg −1 min −1 for 10 min, then females). Of these subjects, seven young (four males/three females) and 11 older (five males/six females) received increased to 50 mg kg −1 min −1 again for 10 min and subsequently increased to 100 mg kg −1 min −1 . The rate was adrenaline with concomitant trimetaphan. All subjects had weight within 20% of the ideal body weight. They all had a not further increased if the systolic BP decreased below 90 mm Hg. In the young subjects, two continued on normal history, physical examination and biochemistry profile. Only subjects with excellent quality echocardiograms 50 mg kg −1 min −1 and five on 100 mg kg
; in the older group nine continued on 50 and two on were enrolled in the study. The subjects were instructed to refrain from caffeine and alcohol 24 h before each study 100 mg kg
. After haemodynamics had stabilized for 10 min, adrenaline infusion was started as above. morning and not to use any medication during the study. The study was approved by the Human Ethics Committee Heart rate and BP were monitored every 2 min for 10 min periods prior to the start of infusion and twice of the University of Ottawa and written informed consent was obtained. Most of the subjects were also infused with during the last 2-3 min at each rate of infusion. Mean values were used for statistical analysis. Echocardiograms were isoprenaline alone or combined with ganglionic blockade. The effects of age on cardiovascular responses to isoprenaline obtained at the end of the resting period and at the end of each infusion rate. In a subset of patients venous samples for have already been reported [13] . For comparison, the heart rate response to isoprenaline has been presented in Figure 1 . plasma concentrations of catecholamines were drawn at baseline and peak infusion rate, and measured according to model. After testing the homogeneity of slopes, analysis of covariance was used to compare the group effect adjusted Sole & Hussain [14] .
for the covariate (infusion rate). Variables with non linear responses were analysed by ANOVA with repeated measures.
Echocardiography
A P value less than 0.05 was considered statistically significant. The SYSTAT/SYGRAPH software (SYSTAT Echocardiograms were obtained in the supine position using a Toshiba 2-D sonographer SSH-60A. Tracings were recorded Inc., Evanston, IL) was utilized. Data are expressed as mean±s.e. mean. at 50 mm s −1 paper speed. The measurements were made to the nearest millimetre on at least four cardiac cycles during quiet respiration and the results averaged for statistical analysis. Results The measurements were made by the same observer according to the guidelines of the American Society of Baseline haemodynamics Echocardiography. All echocardiograms were obtained by the same research assistant with the subject in the same position, Young and older subjects had similar resting heart rates and blood pressure. The young group had significantly larger in the same intercostal area, and in the same left ventricular (LV) area, just below the tip of the ventral leaflets. The LV end-diastolic, end-systolic and stroke volumes compared with the older group (Table 1 ). These differences were following parameters were measured or calculated: LV enddiastolic and end-systolic dimensions. The end-diastolic and mainly a result of significantly larger volumes in younger males compared with older male or female subjects (Table 2) . end-systolic volumes were estimated by the cube function formula. The stroke volume index, cardiac index and left
Trimetaphan decreased blood pressure, total peripheral resistance (TPRI), LV volumes and stroke volume, but ventricular ejection fraction were calculated accordingly. The end-systolic pressure was estimated from the dicrotic notch increased heart rate thereby maintaining cardiac index (Table 3) . Heart rate increased more (P<0.05) in the young pressure determined from a calibrated carotid pulse recording at baseline and peak infusion. The end-systolic stress was (from 60±2 to 83±4 beats min −1 ) compared with older (from 64±2 to 70±3 beats min −1 ) subjects. calculated as previously described [15] .
Blood pressure and cardiac effects of adrenaline alone Analysis of data
Baseline haemodynamic parameters in the two groups of
In response to increasing rates of adrenaline systolic BP increased more and diastolic BP decreased more in young subjects were compared by unpaired t-test. The doseresponse curves were analysed by multivariate general linear compared with older subjects. Mean arterial pressure showed Adrenaline dose (ng kg 
Older male (6) 40 Adrenaline dose (ng kg
Data represent mean±s.e. mean. For abbreviation, see Table 1 . Number of observations after each dose. None of the dose-response curves differ between the two groups. Since in the older group adrenaline at 80 ng kg −1 min −1 was only infused in two subjects, results for this rate are not included in the older subjects.
only small decreases, not different between the two groups decrease in end-systolic volume index. As a result, older females exhibited the smallest increases in stroke volume (Table 1 ). The larger decrease in diastolic BP was restricted to the young male group (Table 2) . index and in ejection fraction. Whereas heart rate increased similarly in the two groups (Figure 1) , parameters of LV function showed different Blood pressure and cardiac effects of adrenaline with concomitant responses. LV end-diastolic volume showed similar minor trimetaphan increases, but LV end-systolic volume decreased more in the young (Table 1) . This led to larger increases in stroke Adrenaline with concomitant infusion of trimetaphan was administered in seven young and 11 older subjects. The volume (Figure 2 ), ejection fraction (Figure 2) , and cardiac index (Table 1) pressures. Nine of the 11 older subjects could not toler-(69±7 [young ] compared with 45±5 ng kg
P=0.02). Both groups exhibited similar increases in plasma ate adrenaline 80 ng kg −1 min −1 because of symptomatic hypotension and only two older subjects received this dose adrenaline by adrenaline with trimetaphan compared with adrenaline alone, but at lower infusion rates for adrenaline of adrenaline. The data acquired at this higher dosage in the aged were therefore not included in the analysis.
with vs without trimetaphan (Table 4 ). Figure 3 (right panel) illustrates the changes in heart rate at the maximal dose of In contrast to the findings without trimetaphan, with concomitant ganglionic blockade adrenaline caused similar adrenaline relative to the plasma concentrations of adrenaline obtained. Adrenaline alone caused similar increases in plasma BP and cardiac chronotropic and inotropic changes in young and older subjects (Table 3 ; Figures 1-2) . Thus, systolic and adrenaline and in heart rate in the young and older groups. With ganglionic blockade, adrenaline again caused similar diastolic BP, heart rate, LV end-systolic and stroke volume as well as cardiac index, ejection fraction, systolic ejection increases in heart rate and plasma adrenaline in the two groups. Comparison of the findings without and with rate and end-systolic wall stress all changed to a similar extent in the two groups. Trimetaphan caused a leftward trimetaphan showed enhanced responses to adrenaline combined with trimetaphan in both the young ( P<0.01) shift of the adrenaline dose-response relationship for heart rate (Figure 1) , systolic blood pressure and-to a less and older (P<0.05) group. extent-most parameters of LV function. Figure 3 [old](P=NS) without trimethaphan, and 69±7
[young ] compared with tended to receive a higher maximal dose of adrenaline Tables 1,3 ). This pattern of changes may suggest that both agents activate the arterial to infusion of isoprenaline. Thus, ageing did not affect the increase in heart rate by adrenaline, either alone or with baroreflex, resulting in an increase in vagal tone and decrease in cardiac sympathetic tone, thereby blunting the increases concomitant ganglionic blockade. On the other hand, ageing blunted the increases in systolic BP and LV performance as in heart rate and LV function. However, combined with trimetaphan adrenaline causes higher plasma concentrations well as the decreases in diastolic BP caused by adrenaline, but these differences were no longer present with concomi- (Table 4 ) of circulating adrenaline compared with infusion of adrenaline alone, which also explains part of the enhanced tant ganglionic blockade. In contrast, responses of heart rate and LV function to the non-selective b-adrenoceptor agonist responses (Figure 3 ). isoprenaline are clearly decreased in older subjects, when combined with ganglionic blockade [13] .
Ageing and cardiovascular responses to adrenaline The cardiovascular effects of adrenaline in man have been well documented. For example, Harris et al. [16] showed Whereas ganglionic blockade unmasks the decreased chronotropic responses to b-receptor stimulation by isoprenaline that adrenaline at a rate of 5 mg min −1 increased heart rate, stroke volume, cardiac output and systolic BP. The increase with ageing (Figure 1 ), such a decrease does not become apparent for adrenaline (Figure 1 and 3) . Assuming that in LV function relates at least in part to direct effects on myocardial contractility [17] , although effects on venous decreased b-receptor mediated responses are indeed present [20] , at least two explanations are possible for this difference return [18] likely contribute. We previously reported the rate-related changes in above parameters by adrenaline [19] in response to the two agonists. Whereas isoprenaline stimulates both b 1 and b 2 receptors in the sinus node, and the present data are similar in this regard. b 2 -receptors appear to play a major role in the increase in heart rate adrenaline mainly stimulates b 2 -receptors [19] . Although in ventricles both b 1 -and b 2 -mediated responses decrease with caused by adrenaline, whereas effects on LV function appear to be mediated primarily via b 1 -receptors [19] .
ageing [20] , it is possible that in the sinus node ageing preferentially affects b 1 -mediated responses and to a less Without ganglionic blockade, adrenaline and isoprenaline cause rather similar cardiovascular responses. With ganglionic extent b 2 -responses, thereby maintaining heart rate responses to adrenaline. Alternatively, neuronal uptake of adrenaline blockade, isoprenaline decreases LV end diastolic volume, and stroke volume and systolic BP no longer increase [13] .
may have been decreased in the older subjects. This wouldat similar plasma concentrations (Table 4 )-result in higher In contrast, adrenaline maintained LV end-diastolic volume, still increased stroke volume and systolic BP, and actually concentrations around the synaptic cleft, which would compensate for a decrease in b-receptor mediated responses. increased cardiac index even more than adrenaline alone. This pattern of changes suggests that in the presence of However, there is no consensus about the effect of ageing on pre-synaptic neuronal uptake of catecholamines [3, 8, ganglionic blockade adrenaline has a larger effect on venous return, but isoprenaline less. This difference may relate to 9]. The older subjects exhibited a similar increase in circulating levels of adrenaline despite a somewhat lower a-receptor stimulation by adrenaline.
Whereas the effects of the arterial baroreflex on the dose of exogenous adrenaline suggesting that decreased clearance and uptake may indeed occur with ageing. A haemodynamic responses to isoprenaline have been studied extensively [13] , as far as we are aware of, no studies have decrease in clearance with ageing has previously been demonstrated for noradrenaline [21] . addressed this interaction for adrenaline. As shown in Figure 1 , ganglionic blockade clearly enhances the heart rate Regarding the effects of adrenaline on LV function, compared with the older subjects the young subjects showed responses to infusion of both adrenaline and isoprenaline. The effects on LV function by adrenaline are enhanced as an enhanced LV emptying (i.e., larger decrease in LV end-systolic volume, and larger increases in stroke volume, References ejection fraction and cardiac index) in response to adrenaline. Since systolic ejection rate increased similarly in the two adrenaline this decrease appears to be compensated by other
